Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia-Reference-Cited by-同舟云学术

Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia

Published:2006 Issue:12 Volume:107 Page:2801-2806
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Strasser-Weippl Kathrin,Steurer Michael,Kees Mathias,Augustin Florian,Tzankov Alexandar,Dirnhofer Stephan,Fiegl Michael,Simonitsch-Klupp Ingrid,Gisslinger Heinz,Zojer Niklas,Ludwig Heinz

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference13 articles.

1. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

2. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement

3. Clonal Karyotype Abnormalities in Erythroid and Granulocyte-Monocyte Precursors in Polycythaemia Vera and Myelofibrosis

4. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome Abnormalities in Hematological Malignancies and Its Clinical Significance;Down Syndrome and Other Chromosome Abnormalities;2022-03-23

2. Prognostic models in the myeloproliferative neoplasms;Blood Reviews;2020-07

3. Detection of mutations inJAK2exons 12-15 by Sanger sequencing;International Journal of Laboratory Hematology;2015-09-11

4. Chronic myeloproliferative neoplasms;Cancer Cytogenetics;2015-06-26

5. Molecular Diagnostics of Myeloid Neoplasms;Molecular Pathology and Diagnostics of Cancer;2013-09-06